Glaukos Corp (GKOS)
Fixed asset turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 301,165 | 266,924 | 278,319 | 211,679 | 233,795 |
Property, plant and equipment | US$ in thousands | 103,212 | 94,403 | 68,969 | 24,008 | 22,056 |
Fixed asset turnover | 2.92 | 2.83 | 4.04 | 8.82 | 10.60 |
December 31, 2023 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $301,165K ÷ $103,212K
= 2.92
The fixed asset turnover ratio for Glaukos Corporation has shown a downward trend over the past five years, decreasing from 10.74 in 2019 to 3.05 in 2023. This indicates that the company's efficiency in generating revenue from its fixed assets has declined. A decreasing fixed asset turnover may suggest that the company is not utilizing its fixed assets as effectively as in previous years, potentially leading to inefficiencies or underutilization of resources. Further analysis is recommended to identify the root causes of this trend and potential strategies for improvement.
Peer comparison
Dec 31, 2023
Company name
Symbol
Fixed asset turnover
Glaukos Corp
GKOS
2.92
3M Company
MMM
3.57
Artivion Inc
AORT
9.56
Baxter International Inc
BAX
3.35
Becton Dickinson and Company
BDX
2.95
Boston Scientific Corp
BSX
4.89
DexCom Inc
DXCM
3.24
Embecta Corp
EMBC
4.16
Globus Medical
GMED
2.67
Haemonetics Corporation
HAE
8.33
ICU Medical Inc
ICUI
3.69